Sponsor

CTI Clinical Trial and Consulting Services

Clinical research sponsor

Published trials6
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

6 shown
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesNCT04137900 · collaborator · 2019-10-30
UNKNOWN
A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney DiseaseNCT03270956 · collaborator · 2018-04-25
COMPLETED
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney DiseaseNCT02836574 · collaborator · 2016-09-01
COMPLETED
Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)NCT02525263 · collaborator · 2016-07-01
TERMINATED
The AutoloGel™ Post-Market Surveillance (TAPS) ProgramNCT00762138 · collaborator · 2008-09-01
TERMINATED
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart FailureNCT00323037 · collaborator · 2006-03-01
COMPLETED

Sponsor roles

collaborator6

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.